AARD · Aardvark Therapeutics, Inc.
Market Cap
$126.71M
Shares
21.88M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-09-15 | VICKERS VENT GLB DEEP-TECH FND I LP | Director, 10% Stockholder | 10,360 | 2025-09-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-02 | VICKERS VENT GLB DEEP-TECH FND I LP | Director, 10% Stockholder | 20,000 | 2025-09-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-08-28 | VICKERS VENT GLB DEEP-TECH FND I LP | Director, 10% Stockholder | 27,691 | 2025-08-28 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–3 of 3 filings
Key facts
CIK
1774857
CUSIP
002942100
13F (30d)
59 filings
59 filers
Visit website
Investor relations